Related Experiment Video

Updated: Jul 20, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
04:16

Electrocardiogram Recordings in Anesthetized Mice using Lead II

Published on: June 20, 2020

The QT interval and psychotropic medications in children: recommendations for clinicians

Paul McNally1, Fiona McNicholas, Paul Oslizlok

  • 1Department of Paediatric Cardiology, Our Lady's Hospital for Sick Children, Crumlin, Dublin 12, Ireland.

European Child & Adolescent Psychiatry
|September 1, 2006
PubMed

Insights

Psychotropic medications may prolong the QTc interval in children, increasing arrhythmia risk. Careful monitoring and clinical recommendations are crucial for safe psychotropic drug use in pediatric patients.

Area of Science:

  • Pediatric Pharmacology
  • Cardiology
  • Psychiatry

Background:

  • Increased use of psychotropic medications in children.
  • Case reports of sudden death in pediatric patients using these drugs.
  • Concerns regarding ventricular arrhythmias and QTc interval prolongation.

Purpose of the Study:

  • To discuss the potential of psychotropic drugs to prolong the QTc interval in children.
  • To examine factors contributing to cardiac conduction abnormalities.
  • To provide clinical recommendations for prescribing and monitoring these medications.

Main Methods:

  • Review of case reports and existing literature.
  • Analysis of electrocardiographic (ECG) findings, specifically QTc interval.
  • Identification of risk factors for QTc prolongation.

Main Results:

  • Certain psychotropic medications are associated with QTc interval prolongation in children.
  • Genetic susceptibility, cardiac disease, drug clearance, and concomitant medications are contributing factors.
  • Electrocardiographic abnormalities are a significant concern.

Conclusions:

  • Psychotropic drug use in children requires careful consideration of cardiac risks.
  • Monitoring QTc interval and other cardiac parameters is essential.
  • Adherence to clinical guidelines can mitigate potential adverse events.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...